why is semaglutide being banned GLP-1 weight-loss drugs are a hot health topic. Now, critics are debating whether the medications should be in sports for potentially performance-enhancing drugs. https://fox5sandiego.com/news/critics-concerned-glp-1-drugs-may-give Export of Novo Nordisk's Ozempic

Still early days, and real-world data will be essential

Many patients are on a combination of an SGLT2 inhibitor with a GLP-1 receptor agonist or tirzepatide (a dual agonist) and have incredible success without adverse reactions, but we are still figuring out the patient characteristics that would put them at higher risk of poor outcomes. Eli J

But naming is not the same as seeing

A Northeastern pharmacy professor says people seeking weight loss drugs may be able to get help from patient financial assistance programs and alternative medications

No prescription is required because these compounds are sold strictly for in vitro and analytical research